My Watchlist

Top Indices

Nasdaq Composite

SPX

My Portfolio

Teva Pharmaceutical Industries Limited American Depositary Shares (NY:TEVA)

24.21 -0.07 (-0.29%)

Official Closing Price Updated: 7:00 PM EST, Nov 21, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Teva Pharmaceutical Industries Limited American Depositary Shares

< Previous 1 2

...

24 25 26 27 28 29 30 31 Next >

Late-Breaking Data at the International Headache Society & European Headache Federation Joint Congress 2021 Showed AJOVY® (fremanezumab-vfrm) Injection Reduced More Monthly Migraine Days in a Network Meta-Analysis Study with Atogepant and Rimegepant

September 08, 2021

From Teva Pharmaceutical Industries Limited

Via Business Wire

The Daily Biotech Pulse: Merck Releases Twin Dose Of Positive Tidings, Astellas Voluntarily Pauses Gene Therapy Study, Ascendis Offering ↗

September 01, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 31) AC Immune SA (NASDAQ: ACIU...

Via Benzinga

Understanding Teva Pharmaceutical Indus's Unusual Options Activity ↗

August 10, 2021

On Tuesday, shares of Teva Pharmaceutical Indus (NYSE:TEVA)...

Via Benzinga

The Daily Biotech Pulse: Pfizer, Bristol-Myers Squibb Earnings, Amgen Goes Shopping, GlaxoSmithKline-Vir's COVID-19 Antibody Treatment Supply Deal ↗

July 28, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 27) Bio-Rad Laboratories, Inc...

Via Benzinga

Earnings Scheduled For July 28, 2021 ↗

July 28, 2021

Companies Reporting Before The Bell • Barclays (NYSE:BCS) is likely to report quarterly earnings at $0.55 per share on revenue of $7.90 billion. • United...

Via Benzinga

Teva-MedinCell's Schizophrenia Treatment Candidate Under FDA Review ↗

September 01, 2021

The FDA has accepted Teva Pharmaceutical Industries Ltd (NYSE: TEVA) and MedinCell's marketing application seeking approval for TV-46000/mdc-IRM in...

Via Benzinga

Attention Biotech Investors: Mark Your Calendar For September PDUFA Dates ↗

August 31, 2021

August proved to be a mixed month for regulatory approvals, with the Food and Drug Administration approving a few, turning down a few others and delaying the remaining. New...

Via Benzinga

Showcasing Teva’s Commitment to Helping Patients Have More Migraine-Free Days, 18 Abstracts will be presented, Including One Late-Breaker, on AJOVY® (fremanezumab-vfrm) Injection at the International Headache Society and European Headache...

August 30, 2021

From Teva Pharmaceutical Industries Limited

Via Business Wire

Teva Announces Post Hoc Analysis of Long-Term Data Examining Treatment with AUSTEDO® (deutetrabenazine) Tablets in Adult Patients with Tardive Dyskinesia

August 20, 2021

From Teva Pharmaceutical Industries Limited

Via Business Wire

Friday the Thirteenth ↗

August 13, 2021

The stock week in points eastward was mixed. The USA markets face a bear correction.

Via Talk Markets

The Real World ↗

August 11, 2021

The rise of the delta has caused markets to drop back after the rises earlier although inflation still remains within a point or two of forecasts at 5.3-5.4% annualized.

Via Talk Markets

10 Health Care Stocks Showing Unusual Options Activity In Today's Session ↗

August 09, 2021

This unusual options alert can help traders discover the next big trading opportunities. Traders will search for circumstances when the market estimation of an option diverges...

Via Benzinga

Delta Outbreak ↗

August 04, 2021

The US market was droopy because of poor private sector jobless numbers.

Via Talk Markets

Know When To Hold 'Em, Know When To Fold 'Em ... ↗

August 02, 2021

A long Monday list identifying some sensible and some impenetrable moves behind today's market in our stocks.

Via Talk Markets

10 Health Care Stocks Showing Unusual Options Activity In Today's Session ↗

August 02, 2021

This unusual options alert can help traders discover the next big trading opportunities. Traders will search for circumstances when the market estimation of an option diverges...

Via Benzinga

News Overload ↗

July 29, 2021

Today US markets managed a rally despite misses in both the growth and employment data.

Via Talk Markets

62 Biggest Movers From Yesterday ↗

July 29, 2021

Gainers Flora Growth Corp. (NASDAQ: FLGC) surged 63.1% to close at $8.27. The Miami-based cannabis producer confirmed Tuesday it has signed a non-binding letter of intent to...

Via Benzinga

Topics Cannabis

Teva Pharmaceutical Industries (TEVA) Q2 2021 Earnings Call Transcript ↗

July 28, 2021

TEVA earnings call for the period ending June 30, 2021.

Via The Motley Fool

Topics Earnings

Full News Day ↗

July 28, 2021

The US greatly increased its exports of liquified natural gas in the first half-year, to 9.6 billion cubic feet per day, a rise of 42% from a year earlier.

Via Talk Markets

Topics Energy

50 Stocks Moving In Wednesday's Mid-Day Session ↗

July 28, 2021

Gainers Infinity Pharmaceuticals Inc. (NASDAQ: INFI) shares jumped 59.9% to $2.43. Infinity Pharmaceuticals shares tumbled over 31% on Tuesday after the company highlighted the...

Via Benzinga

Teva Stock Falls After COVID-19 Impacts Q2 Top And Bottomline; Lowers FY21 Outlook ↗

July 28, 2021

Teva Pharmaceutical Industries Ltd Q2 sales reached $3.9 billion, increasing 1% Y/Y or decreasing 2% in local currency terms, missing the consensus of $4.04 billion.

Via Talk Markets

Teva Stock Falls After COVID-19 Impacts Q2 Top And Bottomline; Lowers FY21 Outlook ↗

July 28, 2021

Teva Pharmaceutical Industries Ltd (NYSE: TEVA) Q2 sales reached $3.9 billion, increasing 1% Y/Y or decreasing 2% in local currency terms, missing the consensus of $4....

Via Benzinga

Teva Generic Medicines Saved the United States $28.8 Billion in 2020, and a Total of $43.1 Billion Across Major Markets, According to Independent Analysis

July 28, 2021

From Teva Pharmaceutical Industries Limited

Via Business Wire

Recap: Teva Pharmaceutical Q2 Earnings ↗

July 28, 2021

Shares of Teva Pharmaceutical Indus (NYSE:TEVA) fell 2.5% in pre-market trading after the company reported Q2 results. Quarterly Results Earnings per share increased 7.27%...

Via Benzinga

Teva Reports Second Quarter 2021 Financial Results

July 28, 2021

From Teva Pharmaceutical Industries Limited

Via Business Wire

Banned Merger ↗

July 27, 2021

Today stock markets are in disarray after the full horror of Beijing's attack on Chinese capitalism has been understood.

Via Talk Markets

Analyzing Teva Pharmaceutical Indus's Unusual Options Activity ↗

July 23, 2021

On Friday, shares of Teva Pharmaceutical Indus (NYSE:TEVA) saw unusual options activity. After the option alert, the stock price moved down to $8.84. Sentiment: BEARISH Option...

Via Benzinga

Joblessness Surprise ↗

July 22, 2021

Despite higher production for the Emirates the price of oil rose sharply today. More output should cut prices.

Via Talk Markets

Panic Attack ↗

July 21, 2021

The H1 rise in US markets was based on hope for an end to lockdowns.

Via Talk Markets

Understanding Teva Pharmaceutical Indus's Unusual Options Activity ↗

July 21, 2021

Shares of Teva Pharmaceutical Indus (NYSE:TEVA) saw some unusual options activity on Wednesday. Following the unusual option alert, the stock price moved up to $8.98. Sentiment...

Via Benzinga

< Previous 1 2

...

24 25 26 27 28 29 30 31 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.